Shanghai, China

Huan Yun Zhang

This inventor holds 26 USPTO granted patents and 9 published patent applications, primarily in Pharmaceutical Chemistry. Top assignees: Huawei Technologies Co., Limited, Semiconductor Manufacturing International (Beijing) Corporation, Semiconductor Manufacturing International (Shanghai) Corporation. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huan Yun Zhang. Retrieved from https://idiyas.com/inventor/huan-yun-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 88.5

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Shenzhen, CN (2016 - 2019)
  • Hangzhou, CN (2017 - 2019)
  • Shanghai, CN (2014 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Areas of Expertise:
Benfotiamine Derivatives
Crystalline Polymorphs
Semiconductor Structure
Vibration-Damping
Noise-Reducing
Incremental Flanging
Data Packet Processing
Access Network Offloading
Suspension Polymerization
Pharmaceutical Composition
Physical Cell Identifier
3GPP Traffic Offloading
26 patents (USPTO):Explore Patents

Sure, here is the article about inventor Huan Zhang:

Title: Innovator Spotlight: Huan Zhang and His Breakthrough in Benfotiamine Polymorphs

Introduction:

Huan Zhang, a talented inventor based in Shanghai, China, has made significant strides in the field of pharmaceuticals with his groundbreaking patent on crystalline polymorphs of benfotiamine.

Latest Patents:

Huan Zhang's notable patent titled "Crystalline polymorphs of benfotiamine, process for preparation and its use thereof" focuses on five distinct crystalline forms designated as A, B, C, D, and E. These polymorphs exhibit unique properties that make them effective in treating various health conditions such as Vitamin B1 deficiency, metabolic disorders, mental illnesses, diabetes complications, and neurodegenerative diseases.

Career Highlights:

Currently employed at Shanghai Raising Pharmaceutical Co., Ltd., Huan Zhang has demonstrated his expertise in pharmaceutical research and development. His dedication to innovation and discovery has led to the successful identification and characterization of novel crystalline forms of benfotiamine.

Collaborations:

Working alongside talented coworkers Chunjiu Zhong and Yinhua He, Huan Zhang has fostered a collaborative environment aimed at advancing pharmaceutical science and enhancing the effectiveness of medical treatments. Their combined efforts have contributed significantly to the field of pharmacology.

Conclusion:

In conclusion, Huan Zhang's pioneering work in the realm of benfotiamine polymorphs stands as a testament to his ingenuity and dedication to scientific advancement. His contributions have the potential to revolutionize the treatment of various health disorders, ultimately improving the quality of life for countless individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…